Data / Form D filings / Alphyn Biologics, Inc.
Alphyn Biologics, Inc.: Form D filings
Alphyn Biologics, Inc., a biotechnology company in Annapolis, MD, filed 4 Form D notices with the SEC between 2020 and 2024. The latest, on May 20, 2024, reports $1.2 million sold of a $1.8 million offering to 17 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 3724 THOMAS POINT ROAD, Annapolis, MD, 21403
- Phone
- (443) 994-0101
- Industry
- Biotechnology
- Entity type
- Limited Liability Company
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1802325
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 20, 2024 | New notice | $1,759,988 | $1,185,717 | $574,271 | 17 | May 19, 2023 | sec.gov |
| Apr 15, 2024 | New notice | $5,172,484 | $5,172,484 | 18 | Mar 28, 2024 | sec.gov | |
| May 23, 2022 | New notice | $3,499,999 | $2,169,997 | $1,330,002 | 7 | May 19, 2022 | sec.gov |
| Feb 6, 2020 | New notice | $1,500,000 | $800,000 | $700,000 | 5 | Jan 27, 2020 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Steven Pentelnik | Executive Officer | |
| Jeffrey Kossak | Director | |
| Gary Pekoe | Executive Officer, Director | |
| Adel Mikhail | Director | |
| Roger Griggs | Director | |
| Neal Koller | Executive Officer, Director |
Other biotechnology companies in Maryland that filed recently
- Accufy Diagnostics, Inc. $2 million · Oct 28, 2026
- OS Therapies Inc $7.2 million · Oct 23, 2026
- Kaigene, Inc. $55 million · Oct 14, 2026
- Templar Nova, Inc. $7 million · Oct 7, 2026
- Monocacy Therapeutics Inc. $25,000 · Oct 7, 2026
- Seraxis Holdings, Inc. $10 million · Sep 24, 2026
Every Form D from the week of May 20, 2024 · All recent filings in Maryland · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Alphyn Biologics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.